NASDAQ:VSCI

As of March 31, 2015, Vision-Sciences Inc. was acquired by Uroplasty, Inc., in a reverse merger transaction. Vision-Sciences, Inc., through its subsidiaries, designs, develops, manufactures, and markets endoscopy products. It operates through Medical and Industrial segments. The Medical segment designs, manufactures, and sells endoscopy-based products, including flexible fiber and video endoscopes; and EndoSheath disposables. This segment offers cystoscopes to urologists; bronchoscope to intensivists, pulmonologists, thoracic surgeons, and other airway-related physicians; trans-nasal esophagoscopy to general surgeons, primarily bariatric and gastroesophageal reflux disease surgeons, and gastroenterology physicians, as well as ear, nose, and throat (ENT) physicians and others; and ENT endoscopes to ENT physicians and speech pathologists. The Industrial segment designs, manufactures, and sells borescopes products, such as modulars, slim levers, knobs, battery operated portable flexible borescopes, industrial videoscopes, and portable video processors primarily to the aircraft engine manufacturing and aircraft engine maintenance industries. The company distributes its products through direct sales representatives in the United States; and through independent distributors in Europe, Asia, Australia, Canada, the Middle East, Africa, and central and South America. The company was founded in 1987 and is headquartered in Orangeburg, New York.